Detection of Extensive Cross-Neutralization between Pandemic and Seasonal A/H1N1 Influenza Viruses Using a Pseudotype Neutralization Assay

作者: Béatrice Labrosse , Mathieu Tourdjman , Raphaël Porcher , Jérôme LeGoff , Xavier de Lamballerie

DOI: 10.1371/JOURNAL.PONE.0011036

关键词:

摘要: Background Cross-immunity between seasonal and pandemic A/H1N1 influenza viruses remains uncertain. In particular, the extent that previous infection or vaccination by can elicit protective immunity against is unclear. Methodology/principal findings Neutralizing titers (A/Brisbane/59/2007) (A/California/04/2009) were measured using an HIV-1-based pseudovirus neutralization assay. Using this highly sensitive assay, we found a large fraction of subjects who had never been exposed to express high levels neutralizing titers. A significant correlation was seen standard strain. Significantly higher in received 2008-2009. Higher also over 60 years age. Conclusions/significance Our reveal cross-immunity may be more important than previously estimated. This could provide possible explanation relatively mild profile recent pandemic.

参考文章(14)
L. Kamimoto, J. Bresee, L. Finelli, C. Cox, X. Xu, L. Brammer, A. Klimov, N. Cox, T. Wallis, T. Fiore, R. Dhara, S. Epperson, L. Blanton, L. Gubareva, C. Bridges, Update: influenza activity - United States, August 30-October 31, 2009. Morbidity and Mortality Weekly Report. ,vol. 58, pp. 1236- 1241 ,(2009)
L Vaillant, G La Ruche, A Tarantola, P Barboza, for the epidemic intelligence team at InVS, Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Eurosurveillance. ,vol. 14, pp. 19309- ,(2009) , 10.2807/ESE.14.33.19309-EN
L. Garcia-Garcia, J. L. Valdespino-Gomez, E. Lazcano-Ponce, A. Jimenez-Corona, A. Higuera-Iglesias, P. Cruz-Hervert, B. Cano-Arellano, A. Garcia-Anaya, E. Ferreira-Guerrero, R. Baez-Saldana, L. Ferreyra-Reyes, S. Ponce-de-Leon-Rosales, C. Alpuche-Aranda, M. H. Rodriguez-Lopez, R. Perez-Padilla, M. Hernandez-Avila, Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City BMJ. ,vol. 339, ,(2009) , 10.1136/BMJ.B3928
Elizabeth Miller, Katja Hoschler, Pia Hardelid, Elaine Stanford, Nick Andrews, Maria Zambon, Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study The Lancet. ,vol. 375, pp. 1100- 1108 ,(2010) , 10.1016/S0140-6736(09)62126-7
Zheng Xing, Carol J. Cardona, Preexisting immunity to pandemic (H1N1) 2009. Emerging Infectious Diseases. ,vol. 15, pp. 1847- 1849 ,(2009) , 10.3201/EID1511.090685
Antoine Nougairède, Laetitia Ninove, Christine Zandotti, Nicolas Salez, Karine Mantey, Noémie Resseguier, Céline Gazin, Didier Raoult, Rémi N. Charrel, Xavier de Lamballerie, Novel virus influenza A (H1N1sw) in South-Eastern France, April-August 2009. PLOS ONE. ,vol. 5, ,(2010) , 10.1371/JOURNAL.PONE.0009214
Kathy Hancock, Vic Veguilla, Xiuhua Lu, Weimin Zhong, Eboneé N Butler, Hong Sun, Feng Liu, Libo Dong, Joshua R DeVos, Paul M Gargiullo, T Lynnette Brammer, Nancy J Cox, Terrence M Tumpey, Jacqueline M Katz, None, Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus The New England Journal of Medicine. ,vol. 361, pp. 1945- 1952 ,(2009) , 10.1056/NEJMOA0906453
J. A. Greenbaum, M. F. Kotturi, Y. Kim, C. Oseroff, K. Vaughan, N. Salimi, R. Vita, J. Ponomarenko, R. H. Scheuermann, A. Sette, B. Peters, Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 20365- 20370 ,(2009) , 10.1073/PNAS.0911580106
Charmaine Gittleson, Connie Leggio, Gunter F. Hartel, Wilson Hu, Michael H. Lai, Gail Dawson, Michael E. Greenberg, Jillian Bennet, Christine H. Wichems, Diane Washington, Russell L. Basser, Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine — Preliminary Report ,(2009)
G. Del Giudice, K. J. Stittelaar, G. van Amerongen, J. Simon, A. D. M. E. Osterhaus, K. Stohr, R. Rappuoli, Seasonal Influenza Vaccine Provides Priming for A/H1N1 Immunization Science Translational Medicine. ,vol. 1, ,(2009) , 10.1126/SCITRANSLMED.3000564